Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-024488
Filing Date
2025-08-04
Accepted
2025-08-04 08:39:08
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A gnpx20250708_defa14a.htm DEFA14A 86492
2 aacr_logo.jpg GRAPHIC 16362
3 ada_logo.jpg GRAPHIC 21484
4 asco_logo.jpg GRAPHIC 20415
5 asg_logo.jpg GRAPHIC 25227
6 cell.jpg GRAPHIC 46521
7 gen.jpg GRAPHIC 14703
8 genp.jpg GRAPHIC 4174
9 image1.jpg GRAPHIC 54286
10 image2.jpg GRAPHIC 65312
11 image3.jpg GRAPHIC 7103
12 image5.jpg GRAPHIC 7618
13 milestones.jpg GRAPHIC 84291
14 phase2.jpg GRAPHIC 29867
15 sig01.jpg GRAPHIC 4606
  Complete submission text file 0001437749-25-024488.txt   642760
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38244 | Film No.: 251178246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)